NCT00250614View on ClinicalTrials.gov

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

PHASE3CompletedINTERVENTIONAL

Enrollment

452

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions

Depressive Disorder

Interventions

DRUG

Saredutant succinate (SR48968C)

Trial Locations (1)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00250614 - An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression | Biotech Hunter | Biotech Hunter